Showing 1 - 6 results of 6 for search 'Richard A. Morgan', query time: 0.03s Refine Results
  1. 1
    Genetic Modification of T Cells

    Genetic Modification of T Cells by Richard A. Morgan, Benjamin Boyerinas

    Published 2016-04-01
    Get full text
    Article
  2. 2
    Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancer.

    Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancer. by Daniel Abate-Daga, Daniel E Speiser, Nachimuthu Chinnasamy, Zhili Zheng, Hui Xu, Steven A Feldman, Steven A Rosenberg, Richard A Morgan

    Published 2014-01-01
    Get full text
    Article
  3. 3
    409 Development of ex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics

    409 Development of ex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics by Richard A Morgan, David J Rawlings, Richard G James, Jasmine N Edelstein, Tyler F Hill, Michael D Leiken, Katherine M Molloy, Glory Adekanye, Caroline Bullock, Adam S Lazorchak, Ken-Edwin Aryee, Sean P Arlauckas

    Published 2023-11-01
    Article
  4. 4
    Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences

    Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences by Richard A. Morgan, Feiyang Ma, Mildred J. Unti, Devin Brown, Paul George Ayoub, Curtis Tam, Lindsay Lathrop, Bamidele Aleshe, Ryo Kurita, Yukio Nakamura, Shantha Senadheera, Ryan L. Wong, Roger P. Hollis, Matteo Pellegrini, Donald B. Kohn

    Published 2020-06-01
    Get full text
    Article
  5. 5
    AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

    AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines by Liyang Zhang, John A. Zuris, Ramya Viswanathan, Jasmine N. Edelstein, Rolf Turk, Bernice Thommandru, H. Tomas Rube, Steve E. Glenn, Michael A. Collingwood, Nicole M. Bode, Sarah F. Beaudoin, Swarali Lele, Sean N. Scott, Kevin M. Wasko, Steven Sexton, Christopher M. Borges, Mollie S. Schubert, Gavin L. Kurgan, Matthew S. McNeill, Cecilia A. Fernandez, Vic E. Myer, Richard A. Morgan, Mark A. Behlke, Christopher A. Vakulskas

    Published 2021-06-01
    Get full text
    Article
  6. 6
    Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines

    Author Correction: AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines by Liyang Zhang, John A. Zuris, Ramya Viswanathan, Jasmine N. Edelstein, Rolf Turk, Bernice Thommandru, H. Tomas Rube, Steve E. Glenn, Michael A. Collingwood, Nicole M. Bode, Sarah F. Beaudoin, Swarali Lele, Sean N. Scott, Kevin M. Wasko, Steven Sexton, Christopher M. Borges, Mollie S. Schubert, Gavin L. Kurgan, Matthew S. McNeill, Cecilia A. Fernandez, Vic E. Myer, Richard A. Morgan, Mark A. Behlke, Christopher A. Vakulskas

    Published 2021-07-01
    Get full text
    Article

Search Tools: